Alireza Khanteymoori | Artificial Intelligence | Editorial Board Member

Published on by Best Achievements

Dr. Alireza Khanteymoori | Artificial Intelligence | Editorial Board Member 

University of Freiburg | Germany

Dr. Alireza Khanteymoori is a distinguished scientific researcher and lecturer at the University of Freiburg, recognized for his extensive contributions at the intersection of artificial intelligence, neuroscience, and bioinformatics. With more than 15 years of academic and research leadership, he has conceived, directed, and supervised numerous high-impact projects spanning brain world models, cognitive neuroscience, diffusion tensor imaging, brain network analysis, and machine learning applications in life sciences. His professional portfolio includes leading a Machine Learning and Bioinformatics Laboratory, mentoring 5 Ph.D. candidates and over 30 master’s and bachelor’s theses, and developing advanced deep learning and probabilistic graphical models for genomics, neuroimaging, drug discovery, and single-cell data analysis. Dr. Khanteymoori has produced an impressive body of scientific work, reflected in 44 documents, 563 citations, and an h-index of 11, demonstrating the global impact and reach of his research. His strong technical expertise spans Python, R, MATLAB, TensorFlow, PyTorch, Keras, OpenCV, and scikit-learn, complemented by hands-on experience designing machine learning pipelines within platforms such as Galaxy. Beyond academia, he has held executive and technical leadership positions, contributing to industrial innovation in e-payment systems and intelligent software solutions. His academic service includes reviewing for major scientific journals, organizing specialized workshops in machine learning and meta-analysis, and delivering graduate-level courses in AI, bioinformatics, and data-driven life sciences. Awarded multiple distinctions, he continues to advance interdisciplinary research that bridges computation and biology, driving impactful solutions to complex scientific and medical challenges.

Profile: Scopus 

Featured Publications 

Khanteymoori, A. (n.d.). Advancing CRISPR with deep learning: A comprehensive review of models and databases.

Khanteymoori, A. (2025). Topological biomarkers of Alzheimer’s disease from functional brain network analysis. Current Alzheimer Research.

Khanteymoori, A. (2024). DTMP-prime: A deep transformer-based model for predicting prime editing efficiency and PegRNA activity. Molecular Therapy – Nucleic Acids.

Khanteymoori, A. (2024). StructmRNA: A BERT-based model with dual-level and conditional masking for mRNA representation. Scientific Reports.

Rufei Wei | Metallurgical Engineering | Editorial Board Member

Published on by Best Achievements

Assoc. Prof. Dr. Rufei Wei | Metallurgical Engineering | Editorial Board Member 

Anhui University of Technology | China

Dr. Rufei Wei, Associate Professor and Ph.D. Supervisor in the School of Metallurgical Engineering at Anhui University of Technology, is a distinguished researcher recognized for his influential contributions to low-carbon metallurgical innovation and sustainable resource utilization. With 18 h-index, 74 documents, and 1,085 citations, his scholarly impact spans advanced ironmaking technologies, solid waste recycling, and biomass metallurgy. Dr. Wei earned his Ph.D. jointly from the Beijing University of Science and Technology and the University of Western Ontario, followed by progressive academic roles that highlight his leadership in metallurgical engineering education and research. His scientific work focuses on low-carbon ironmaking theory, biomass-based reduction processes, and high value utilization of industrial solid wastes, supporting the development of green and circular metallurgical systems. He has secured multiple national and provincial research projects and contributed extensively to industrial collaborative programs involving blast furnace optimization, coal injection processes, biomass coupling reactions, and innovative resource-efficient material technologies. Dr. Wei holds numerous authorized patents, including methods for biomass gasification, iron-containing pellet preparation, desulfurization ash oxidation, and calcium sulfate whisker production demonstrating strong translational research capacity. Actively engaged in academic service, he serves on youth committees, editorial boards of leading journals, and as a reviewer for prominent international publications. His achievements have earned him major recognitions such as the Metallurgical Science and Technology Award, the Anhui Provincial Teaching Achievement Award, and selection as a Young Top-Notch Talent of Anhui University of Technology. Through mentoring, he has guided students to success in innovation and entrepreneurship competitions, further reflecting his commitment to academic excellence and talent cultivation.

Profile: Scopus | Orcid

Featured Publications 

Wei, R.,, [co-authors]. (2026). A novel approach with high-calcium and low-carbon for treating zinc-bearing dust: Reaction characteristics, energy-mass balance and economic feasibility. Separation and Purification Technology.

Wei, R.,, [co-authors]. (2025). Analysis of the synchronous enhancement in CO₂ sequestration by steel slag using steam in flue gas: Performance and mechanism. Journal of Cleaner Production.

Wei, R.,, [co-authors]. (2025). Mechanism of direct CO₂ sequestration by alkali metal K-activated steel slag. Journal of Iron and Steel Research International.

Wei, R.,, [co-authors]. (2025). Enhancing carbon sequestration in steel slag: Multifaceted strategies, reaction mechanisms, and industrial prospects.

Wei, R.,, [co-authors]. (2025). Combustion characteristics of pulverized coal for blast furnace: A study based on an innovative extreme temperature increase method. Fuel.

Liming Ge | Economics | Editorial Board Member

Published on by Best Achievements

Assist. Prof. Dr. Liming Ge | Economics | Editorial Board Member 

Shanghai Jiaotong Univeristy | China

Dr. Ge Liming is an emerging scholar in Energy Economics, Regional Policy, and Environmental Sustainability, currently affiliated with Shanghai Jiao Tong University and guided by Adviser Shao Shuai. With a strong academic foundation built through a master’s degree from the University of Shanghai for Science and Technology and doctoral training at Shanghai University of Finance and Economics, he has established himself as a high-achieving researcher, maintaining top academic standing  and earning multiple scholarships and honorary titles. His research output is widely recognized, reflected in 303 citations, 25 published documents, and an h-index of 10, highlighting his growing influence in the fields of energy policy and sustainability transitions. Dr. Ge possesses strong quantitative and empirical research capabilities, demonstrated through mastery of Stata, SPSS, ArcGIS, and EViews, and supported by professional certifications in accounting, securities, and information technology. He has participated in several major national and institutional research projects, contributing to studies on green development, energy productivity, industrial spatial governance, and pollution-economy interactions. His academic excellence is further evidenced by numerous competition awards, including top prizes in national contests on energy economics, mathematical modeling, and innovation. Dr. Ge has actively engaged with the academic community by presenting at prominent national forums and symposiums focused on economics, energy, environment, and regional development. Through rigorous research, interdisciplinary expertise, and sustained academic contributions, he continues to advance critical insights into energy efficiency, regional coordination, and sustainable development pathways.

Profile: Scopus | Orcid

Featured Publications 

Ge, Liming (2025). The effect of low-carbon city construction on PM2.5: Evidence from China. Energy Economics.

Ge, Liming (2025). Impacts of global manufacturing transfer on energy intensity, consumption, and transition: An industry linkage perspective. Habitat International.

Tzong-Shyuan Lee | Biomedicine | Best Researcher Award

Published on by Best Achievements

Prof. Tzong-Shyuan Lee | Biomedicine | Best Researcher Award 

National Taiwan University | Taiwan

Dr. Tzong-Shyuan Lee, DVM, Ph.D., is a distinguished Professor in the Graduate Institute and Department of Physiology at the College of Medicine, National Taiwan University, Taipei, Taiwan. His extensive research focuses on the pathophysiology of age-related diseases, particularly cardiovascular and neurodegenerative disorders. Dr. Lee’s investigations integrate clinical reagents, nutritional compounds, and traditional herbal medicines through comprehensive in vitro and in vivo approaches to explore therapeutic interventions. His pioneering work has identified several molecular targets and elucidated key mechanistic pathways involved in cardiovascular dysfunction, fatty liver disease, chronic kidney disease, and Alzheimer’s disease. With an impressive scholarly record of 144 publications, 7,843 citations across 6,667 documents, and an h-index of 50, Dr. Lee’s contributions have significantly advanced biomedical research on vascular biology and aging. He has also demonstrated outstanding editorial leadership as Associate Editor for Frontiers in Physiology and Journal of Physiological Investigator, and as Academic Editor for Scientifica (Vascular Medicine Section), Exploration of Endocrine and Metabolic Diseases, and Aging Advances. His expertise is further reflected in his role as an invited reviewer for more than 185 scientific journals. Beyond his research and editorial activities, Dr. Lee has provided exemplary academic leadership as Director of the Department and Graduate Institute of Physiology and as Chairman of the Institutional Animal Care and Use Committee at National Taiwan University. His sustained research excellence, coupled with his leadership and service, underscores his status as a leading figure in cardiovascular and aging-related disease research.

Profile: Scopus | Orcid

Featured Publications 

Lee, T.-S., et al. (2025). Genetic deletion of TRPM8 channels restores microvascular function and mitigates chronic kidney disease progression. Free Radical Biology and Medicine.

Lee, T.-S., et al. (2025). Bromelain enhances nitric oxide bioavailability: Bradykinin's link to TRPV1/Ca²⁺/AMPK/autophagy signaling. Biomedicine and Pharmacotherapy.

Lee, T.-S., et al. (2025). Rac1 signaling mediates the protection of apigenin against hepatic lipid accumulation and insulin resistance. Biomedicine and Pharmacotherapy.

Lee, T.-S., et al. (2025). Bromelain prevents Alzheimer's disease progression by suppressing oxidative stress and upregulating apolipoprotein A1 in 5x familial Alzheimer's disease transgenic mice. Journal of Agriculture and Food Research.

Lee, T.-S., et al. (2025). HMGB1 regulates adipocyte lipolysis via caveolin-1 signaling: Implications for metabolic and cardiovascular diseases. International Journal of Molecular Sciences.

Dehua Chang | Regenerative Medicine Research | Best Researcher Award

Published on by Best Achievements

Dr. Dehua Chang | Regenerative Medicine Research | Best Researcher Award 

University of Tokyo Hospital | Japan

Dr. Dehua Chang, M.D., Ph.D., is a highly accomplished researcher and clinician specializing in cardiovascular surgery and regenerative medicine. He currently serves as a Specially Appointed Associate Professor at the Department of Cell Therapy in Regenerative Medicine, University of Tokyo Hospital, and holds multiple visiting professorships at leading institutions, including Fudan University, Shanghai Jiao Tong University, and Zhengzhou University. With a prolific academic and professional background spanning Japan, China, Europe, and the United States, Dr. Chang has made significant contributions to stem cell therapy, tissue engineering, and cardiac regeneration. His work has been widely recognized, with 29 published documents, 838 citations, and an h-index of 15, reflecting his influential research impact in the field. He has developed several innovative patents related to cell sheet technologies and mesenchymal stem cell applications, advancing translational approaches in regenerative medicine. As a member of the Japanese Society for Regenerative Medicine and a reviewer for leading journals such as Stem Cell Research & Therapy, Regenerative Therapy, and Acta Biomaterialia, Dr. Chang contributes extensively to scientific peer review and editorial excellence. His clinical and research expertise encompasses cell-based therapies for ischemic heart disease, heart failure, osteoarthritis, and vascular disorders, with a focus on the industrialization and clinical application of stem cell sheet products. Fluent in Chinese, English, and Japanese, Dr. Chang bridges international collaboration, academic leadership, and innovation in regenerative cardiovascular medicine, positioning him as a global expert in translational medical research and clinical cell therapy.

Profile: Scopus 

Featured Publications 

Wang, Y.-H., Liu, T.-T., Guo, Y.-P., Zhu, S.-J., Liao, Z.-M., Song, J.-M., Zhu, X.-M., Liang, J.-L., Nasser, M. I., Liu, N.-B., Chang, D.-H., Zhu, P., & Yao, B.* (2025). Integrating melt electrospinning writing and microfluidics to engineer a human cardiac microenvironment for high-fidelity drug screening. Bioactive Materials.

Zhu, S., Xuan, J., Shentu, Y., Kida, K., Kobayashi, M., Wang, W., Ono, M., & Chang, D.* (2024). Effect of chitin-architected spatiotemporal three-dimensional culture microenvironments on human umbilical cord-derived mesenchymal stem cells. Bioactive Materials

Ke Li | Nanotechnology | Best Researcher Award

Published on by Best Achievements

Dr. Ke Li | Nanotechnology | Best Researcher Award 

Wuxi Ninth People’s Hospital Affiliated to Soochow University | China

Dr. Ke Li is an accomplished researcher specializing in orthopaedic surgery with a Ph.D. from Yangzhou University, holding prior degrees in Orthopaedic Surgery (M.M., China Medical University) and Clinical Medicine (B.M., Fujian University of Traditional Chinese Medicine). His research primarily focuses on constructing bio-nanomaterials that target various effector cells in the bone aging microenvironment to develop innovative anti-osteoporosis therapies. As the Principal Investigator of the Jiangsu Provincial Postgraduate Research & Practice Innovation Program, he leads a project on developing a nanozyme-based gene-editing platform for bone cell coupling and osteoporosis treatment. Dr. Li has an impressive portfolio of 23 scholarly publications, accumulating 391 citations and an h-index of 11, underscoring his scientific impact and research excellence. His notable works include pioneering studies on nitric oxide nanopumps for bone marrow regeneration (Nature Communications), cellular senescence mechanisms in skeletal diseases (Bone Research), and nanozyme-based gene editing for reversing osteoporosis (Nano Today). Additionally, his research extends to drug delivery systems, chemo-immunotherapy, and tumor microenvironment modulation, with publications in high-impact journals such as Bioactive Materials, Materials & Design, and Frontiers in Oncology. Dr. Li’s contributions significantly advance the understanding of bone aging, nanomedicine, and regenerative therapy, providing a foundation for translational applications in orthopaedics and related biomedical fields. His innovative approach to integrating nanotechnology with molecular biology continues to drive breakthroughs in therapeutic strategies for skeletal and degenerative diseases.

Profile: Scopus 

Featured Publications 

Li, K., Hu, S., Li, H., et al. (2025). Remodeling adipocytes’ lipid metabolism with a polycation loaded enzyme-active framework reverses osteoporotic bone marrow. Nature Communications.

Li, K., Hu, S., Chen, H., et al. (2025). Cellular senescence and other age-related mechanisms in skeletal diseases. Bone Research.

Guoping Liu | Veterinary Medicine | Best Researcher Award

Published on by Best Achievements

Prof. Guoping Liu | Veterinary Medicine | Best Researcher Award 

Yangtze University | China

Professor Liu Guoping is a distinguished scholar and expert in veterinary medicine with extensive contributions to animal health management and disease prevention. Currently serving as a Professor and Doctoral Supervisor at the College of Animal Science, Yangtze University, he also holds multiple leadership positions, including Director of the Black Pig Research Institute, Director of the Hubei Gongfu Pig Breeding Technology Innovation Center, and Deputy Director of the Environmental Control Innovation Platform under the Provincial Collaborative Innovation Center for Healthy Pig Breeding. His research focuses on early warning, prevention, and eradication of major swine diseases such as African swine fever, PRRS, pseudorabies, and parvovirus. He has pioneered the development of microbial-driven technologies for selenium-rich pig breeding and promoted eco-friendly agricultural models integrating “two farms and one factory.” Professor Liu has applied for invention patents, forming a robust technology protection network. His team has achieved remarkable results in technology and established strategic partnerships with prominent enterprises such as Hubei Gongfu Animal Husbandry Co., Sinopharm Group Animal Health Co., and Jiahe Agricultural and Animal Husbandry Group. A prolific researcher with 25 published documents, 280 citations, and an h-index of 11, he has been recognized with multiple honors, including the Third Prize of the Hubei Provincial Science and Technology Progress Award. His pioneering work has been widely featured in People’s Daily, China Education Daily, and Southern Rural News, highlighting his impactful role in promoting rural revitalization and global cooperation in animal health.

Profile: Scopus 

Featured Publications 

Yi, W., Liu, G., Wang, M., Wang, J., Chen, D., & Shen, J. (2025). Increased nitrogen deposition and airborne particulate matter pollution in the vicinity of intensive animal farms caused by ammonia emissions. Agriculture, Ecosystems & Environment

Zhang, S., Zhao, C., Liu, G., Guo, L., Zhang, R., Yan, J., He, J., & Guo, C. (2025). Monitoring of pathogens carried by imported flies and cockroaches at Shenzhen ports. Tropical Medicine and Infectious Disease.

Rashid Munir | Pharmaceutical Technology | Best Researcher Award

Published on by Best Achievements

Mr. Rashid Munir | Pharmaceutical Technology | Best Researcher Award 

Marburg University | Germany

Dr. Rashid Munir is an enthusiastic PhD researcher specializing in multifunctional nanocarriers for the co-delivery of drugs and genes, currently pursuing his doctoral research at Philipps University of Marburg, Germany. His research focuses on developing lipid-based nanocarriers, including liposomes and lipopolyplexes, for enhanced gene therapy and drug delivery in tumor models. He has extensive expertise in nanomedicine formulation, gene and drug delivery systems, and advanced physico-chemical characterization methods such as MTT, pGFP transfection, DLS, and confocal laser scanning microscopy. His technical proficiency extends to polymeric nanoparticles, dual drug–gene delivery systems, and analytical software such as ImageJ, GraphPad Prism, Origin, and Zetasizer Nano. Dr. Munir’s academic foundation includes an MPhil in Pharmaceutics from Quaid-i-Azam University, Islamabad, and a Doctor of Pharmacy (Pharm-D) from the University of Peshawar. He has published two peer-reviewed scientific articles and authored a master’s thesis on targeted drug delivery for rheumatoid arthritis. His research contributions, cited 48 times across 48 documents, demonstrate a growing impact in the fields of nanomedicine and targeted therapeutics, with an h-index of 1. Beyond research, he has served as a Pharmacist at Tianshi International and a Research Assistant at Quaid-i-Azam University, where he gained valuable experience in formulation design, in vitro assays, and academic mentoring. His commitment to innovation and translational research continues to drive advancements in drug delivery, gene therapy, and cancer nanotechnology

Profile: Scopus 

Featured Publications 

Schöne, L., Klein, S. C., Schorr, D., Preis, E., Engelhardt, K., Diemer, S., Munir, R., Schlüter, S., Schäfer, J., & Bakowsky, U. (2025). Optimizing the antimicrobial photodynamic efficacy of curcumin liposomes to treat pulmonary infections caused by gram-positive bacteria. European Journal of Pharmaceutical Sciences.

Anam Khan | Pharmaceutics | Best Researcher Award

Published on by Best Achievements

Ms. Anam Khan | Pharmaceutics | Best Researcher Award 

Marburg University | Germany

Dr. Anam Sajjad Khan is an enthusiastic Ph.D. researcher at the Philipps University of Marburg, Germany, specializing in nanocarriers for oral and dermal drug delivery. Her research expertise encompasses physicochemical characterization, formulation optimization, and ex-vivo study models for enhancing drug bioavailability and therapeutic performance. With a strong academic foundation, she holds a Master of Philosophy in Pharmaceutics and a Doctor of Pharmacy degree from Quaid-i-Azam University, Islamabad, where she developed a keen interest in nanomedicine and cosmetology. Her doctoral work is focused on developing innovative nanocarrier systems for targeted and controlled drug delivery applications. Dr. Khan has contributed to the scientific community through one published document. Alongside her academic pursuits, she has gained professional experience as a Drug Inspector with the Provincial Health Department of Khyber Pakhtunkhwa, ensuring regulatory compliance within the pharmaceutical sector, and as a Lecturer at Abasyn University Islamabad, where she taught core pharmaceutical subjects and participated in academic committees. Her dedication to research and education has been recognized through multiple awards and honors, including a prestigious DAAD research grant for doctoral studies in Germany and first position in a poster presentation at an international conference. Multilingual in English, German, Urdu, and Pashto, Dr. Khan continues to advance her research in nanotechnology-based drug delivery systems, contributing to the evolving landscape of pharmaceutical sciences and nanomedicine.

Profile: Scopus 

Featured Publications 

Roscettia, L., Keck, C. M., Chaiprateep, E., Sehra, T., Alkhaldi, M., Khan, A. S., Sengupta, S., Busch, L., Kleuser, B., Meinke, M. C., & Klein, A. L. (2025). Enhanced follicular penetration of antiseptics using nanocrystals – investigated via novel hair follicle content removal method. International Journal of Pharmaceutics, 685, Article 122435

Hina Singh | Neuroscience | Best Researcher Award

Published on by Best Achievements

Dr. Hina Singh | Neuroscience | Best Researcher Award 

University of California, Riverside | United States

Dr. Hina Singh, Ph.D., currently serves as an Assistant Project Scientist in the Division of Biomedical Sciences at the School of Medicine, University of California, Riverside, USA. Her research focuses on neuroHIV, neuroimmunology, and nanobiotechnology, with particular expertise in investigating the role of interferon signaling in HIV-associated neurocognitive disorders and methamphetamine-induced neurotoxicity. She possesses extensive experience in neuronal and microglial cell culture, molecular biology, and advanced microscopy techniques, alongside proficiency in nanoparticle synthesis and biosensor development. Dr. Singh’s scholarly contributions are reflected in 55 peer-reviewed publications, accumulating over 2,190 citations and an impressive h-index of 23, highlighting her significant impact in biomedical and nanoscience research. Her scientific journey spans diverse areas, including superparamagnetic iron oxide nanoparticles, gold nanoparticle-based biosensors, and the synthesis of biocompatible nanomaterials for therapeutic applications. She has also been actively involved in mentoring students and collaborating on interdisciplinary research projects bridging neurobiology and nanotechnology. A recipient of multiple international honors such as the Early Career Investigator Travel Award and President’s Scholarship, Dr. Singh continues to advance translational research aimed at understanding molecular mechanisms underlying neuroinflammation, viral neuropathogenesis, and neuroprotective therapeutic strategies.

Profile: Scopus | Orcid 

Featured Publications 

Singh, H., et al. (2025). Medical importance and pharmacokinetics of gold nanoparticles in the human body. Molecular Cancer.

Singh, H., et al. (2025). EphB2-mediated ephrin-B reverse signaling on microglia drives an anti-viral, but inflammatory and neurotoxic response associated with HIV. Journal of Neuroinflammation.

Singh, H., et al. (2025). Advanced nanomaterials for cancer therapy: Gold, silver, and iron oxide nanoparticles in oncological applications.

Singh, H., et al. (2025). Advances in precision oncology using patient-derived organoids and functional biomaterials.

Singh, H., et al. (2024). Interferon-β deficiency alters brain response to chronic HIV-1 envelope protein exposure in a transgenic model of NeuroHIV. Brain, Behavior, and Immunity.